Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea

Authors: Ji-Yeon Shin, Kui Son Choi, Mina Suh, Boyoung Park, Jae Kwan Jun

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Cervical cancer screening is not recommended for women who underwent hysterectomy with no history of cervical intraepithelial neoplasia (CIN) of grade 2 or higher. We aimed to determine the cervical cancer screening rate in Korean women who underwent hysterectomies and compare it to that in women with intact uteri.

Methods

We used data from the 2014–2016 Korean National Cancer Screening Survey; 6807 women aged 30–74 years were included in the study. Participants were asked about their experiences with cervical cancer screening, hysterectomy status, and other variables associated with cancer screening.

Results

The screening rates among women who have undergone a hysterectomy vs. those who have not during the past 2 years were 61.8% (95% confidence interval [CI], 58.8–64.9) and 64.7% (95% CI, 64.1–65.3), respectively. Among younger women (30–44 years) and women with a family history of cancer, those with hysterectomies showed a higher cervical cancer screening rate than those without (77.8% vs. 57.1% and 75.0% vs. 67.1%, respectively).

Conclusions

Despite available evidence and clinical recommendations, a considerable number of Korean women who no longer have a cervix continue to undergo unnecessary cervical cancer screening. It is necessary to identify the exact underlying causes for this phenomenon, and systematic efforts are required to prevent unnecessary screening for women who have undergone a hysterectomy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.CrossRefPubMed
2.
go back to reference Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, et al. Implementation of the National Breast and Cervical cancer Early Detection Program: the beginning. Cancer. 2014;120(suppl 16):2540–8.CrossRefPubMedPubMedCentral Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, et al. Implementation of the National Breast and Cervical cancer Early Detection Program: the beginning. Cancer. 2014;120(suppl 16):2540–8.CrossRefPubMedPubMedCentral
3.
go back to reference DeGroff A, Carter A, Kenney K, Myles Z, Melillo S, Royalty J, et al. Using evidence-based interventions to improve cancer screening in the National Breast and Cervical Cancer Early Detection Program. J Public Health Manag Pract. 2016;22:442–9.CrossRefPubMedPubMedCentral DeGroff A, Carter A, Kenney K, Myles Z, Melillo S, Royalty J, et al. Using evidence-based interventions to improve cancer screening in the National Breast and Cervical Cancer Early Detection Program. J Public Health Manag Pract. 2016;22:442–9.CrossRefPubMedPubMedCentral
4.
go back to reference Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomark Prev. 2005;14:677–86.CrossRef Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Møller H, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomark Prev. 2005;14:677–86.CrossRef
5.
go back to reference Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Changing demographics of cervical cancer in the United States (1973–2008). Gynecol Oncol. 2012;126:330–3.CrossRefPubMed Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA, Plaxe SC. Changing demographics of cervical cancer in the United States (1973–2008). Gynecol Oncol. 2012;126:330–3.CrossRefPubMed
6.
go back to reference Moyer VA, U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880–91.CrossRefPubMed Moyer VA, U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880–91.CrossRefPubMed
7.
go back to reference Suh M, Choi KS, Park B, Lee YY, Jun JK, Lee DH, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat. 2016;48:1–10.CrossRefPubMed Suh M, Choi KS, Park B, Lee YY, Jun JK, Lee DH, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat. 2016;48:1–10.CrossRefPubMed
8.
go back to reference Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017;49:292–305.CrossRefPubMedPubMedCentral Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017;49:292–305.CrossRefPubMedPubMedCentral
9.
go back to reference Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14:CR24–31.PubMed Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14:CR24–31.PubMed
10.
go back to reference Lee EJ, Park HM. Trends in laparoscopic surgery for hysterectomy in Korea between 2007 and 2009. J Obstet Gynaecol Res. 2014;40:1695–9.CrossRefPubMed Lee EJ, Park HM. Trends in laparoscopic surgery for hysterectomy in Korea between 2007 and 2009. J Obstet Gynaecol Res. 2014;40:1695–9.CrossRefPubMed
11.
go back to reference Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy surveillance—United States, 1994–1999. MMWR Surveill Summ. 2002;51:1–8. Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy surveillance—United States, 1994–1999. MMWR Surveill Summ. 2002;51:1–8.
12.
go back to reference Korea National Health Insurance Service. Main surgery statistical yearbook 2015. Wonju: National Health Insurance Service; 2016. Korea National Health Insurance Service. Main surgery statistical yearbook 2015. Wonju: National Health Insurance Service; 2016.
13.
go back to reference US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore: Williams & Wilkins; 1996. p. 105–18. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore: Williams & Wilkins; 1996. p. 105–18.
14.
go back to reference Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, et al. Cervical cancer screening: clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2010;8:1358–86.CrossRef Partridge EE, Abu-Rustum NR, Campos SM, Fahey PJ, Farmer M, Garcia RL, et al. Cervical cancer screening: clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2010;8:1358–86.CrossRef
15.
go back to reference Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147–72.CrossRefPubMedPubMedCentral Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147–72.CrossRefPubMedPubMedCentral
16.
17.
go back to reference Kepka D, Breen N, King JB, Benard VB, Saraiya M. Overuse of papanicolaou testing among older women and among women without a cervix. JAMA Intern Med. 2014;174:293–6.CrossRefPubMedPubMedCentral Kepka D, Breen N, King JB, Benard VB, Saraiya M. Overuse of papanicolaou testing among older women and among women without a cervix. JAMA Intern Med. 2014;174:293–6.CrossRefPubMedPubMedCentral
18.
go back to reference Selvin E, Brett KM. Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women. Am J Public Health. 2003;93:618–23.CrossRefPubMedPubMedCentral Selvin E, Brett KM. Breast and cervical cancer screening: sociodemographic predictors among White, Black, and Hispanic women. Am J Public Health. 2003;93:618–23.CrossRefPubMedPubMedCentral
19.
go back to reference Hahm MI, Chen HF, Miller T, O’Neill L, Lee HY. Why do some people choose opportunistic rather than organized cancer screening? The Korean National Health and Nutrition Examination Survey (KNHANES) 2010-2012. Cancer Res Treat. 2017;49:727–38.CrossRefPubMed Hahm MI, Chen HF, Miller T, O’Neill L, Lee HY. Why do some people choose opportunistic rather than organized cancer screening? The Korean National Health and Nutrition Examination Survey (KNHANES) 2010-2012. Cancer Res Treat. 2017;49:727–38.CrossRefPubMed
20.
go back to reference US Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Am J Nurs. 2003;103:101–9. US Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Am J Nurs. 2003;103:101–9.
21.
go back to reference Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA. 2004;291:2990–3.CrossRefPubMed Sirovich BE, Welch HG. Cervical cancer screening among women without a cervix. JAMA. 2004;291:2990–3.CrossRefPubMed
23.
go back to reference Lee S, Lee YY, Yoon HJ, Choi E, Suh M, Park B, et al. Responses to overdiagnosis in thyroid cancer screening among Korean women. Cancer Res Treat. 2016;48:883–91.CrossRefPubMed Lee S, Lee YY, Yoon HJ, Choi E, Suh M, Park B, et al. Responses to overdiagnosis in thyroid cancer screening among Korean women. Cancer Res Treat. 2016;48:883–91.CrossRefPubMed
24.
go back to reference Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women’s responses to information about overdiagnosis in breast cancer screening in Britain. Br J Cancer. 2014;111:1831–5.CrossRefPubMedPubMedCentral Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women’s responses to information about overdiagnosis in breast cancer screening in Britain. Br J Cancer. 2014;111:1831–5.CrossRefPubMedPubMedCentral
25.
go back to reference Case DO, Andrews JE, Johnson JD, Allard SL. Avoiding versus seeking: the relationship of information seeking to avoidance, blunting, coping, dissonance, and related concepts. J Med Libr Assoc. 2005;93:353–62.PubMedPubMedCentral Case DO, Andrews JE, Johnson JD, Allard SL. Avoiding versus seeking: the relationship of information seeking to avoidance, blunting, coping, dissonance, and related concepts. J Med Libr Assoc. 2005;93:353–62.PubMedPubMedCentral
26.
go back to reference Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17:748–57.CrossRef Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomark Prev. 2008;17:748–57.CrossRef
27.
go back to reference Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control. 2009;20:1–13.CrossRefPubMed Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control. 2009;20:1–13.CrossRefPubMed
28.
go back to reference Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women’s self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomark Prev. 2003;12:1182–7. Caplan LS, McQueen DV, Qualters JR, Leff M, Garrett C, Calonge N. Validity of women’s self-reports of cancer screening test utilization in a managed care population. Cancer Epidemiol Biomark Prev. 2003;12:1182–7.
29.
go back to reference Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Cancer Epidemiol Biomark Prev. 2008;17:777–84.CrossRef Jones RM, Mongin SJ, Lazovich D, Church TR, Yeazel MW. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment. Cancer Epidemiol Biomark Prev. 2008;17:777–84.CrossRef
30.
go back to reference Lee JK, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, et al. Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol. 2013;24:186–203.CrossRefPubMedPubMedCentral Lee JK, Hong JH, Kang S, Kim DY, Kim BG, Kim SH, et al. Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol. 2013;24:186–203.CrossRefPubMedPubMedCentral
Metadata
Title
Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea
Authors
Ji-Yeon Shin
Kui Son Choi
Mina Suh
Boyoung Park
Jae Kwan Jun
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4723-9

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine